NCT03779334 A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03774576 A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants Status COMPLETED Phase PHASE1
NCT03768063 A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03764449 A Study Investigating the Absolute Oral Bioavailability of Balovaptan After Single and Multiple Daily Oral Doses of Balovaptan in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03762681 A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection Status TERMINATED Phase PHASE1
NCT03762018 BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma Status COMPLETED Phase PHASE3
NCT03761849 A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease Status COMPLETED Phase PHASE3
NCT03735121 A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT03726879 A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT03717064 A Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03708328 A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT03698461 Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab Status COMPLETED Phase PHASE2
NCT03695380 A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer Status COMPLETED Phase PHASE1
NCT03693573 A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma Status WITHDRAWN Phase PHASE3
NCT03686332 PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study Status COMPLETED Phase PHASE2
NCT03684044 Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza Status COMPLETED Phase PHASE3
NCT03683251 Extension Study for the Port Delivery System With Ranibizumab (Portal) Status RECRUITING Phase PHASE3
NCT03680365 Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families Status COMPLETED Phase N/A
NCT03677934 A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration Status COMPLETED Phase PHASE3
NCT03677154 Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2